NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Carmaker enters ‘period of exclusivity’ with agency group — with media-buying added during pitch process in surprise move.Read More
